
| Salt Composition: | Ceftriaxone (250mg) + Sulbactam (125mg) |
| Manufacturer: | Epitome Life Sciences |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Epixone-SL 250mg/125mg Injection is a combination medicine used to treat various types of bacterial infections. Epixone-SL 250mg/125mg Injection should only be administered under the supervision of a healthcare professional. Do not miss any scheduled appointments for taking this medicine. The course of the treatment must be completed even if you feel better. Sudden discontinuation of the treatment may affect the potency of the medicine. Some common side effects of this medicine are nausea, vomiting, diarrhea, indigestion, etc. If any of the side effects get aggravated, you must consult your doctor immediately. If you experience any allergic reaction (rashes, itching, swelling, shortness of breath, etc.), you must seek immediate medical help. Before taking this medicine, you should tell your doctor if you are taking any medicines for any health condition. Pregnant or breastfeeding women should also consult with their doctor before taking it. Avoid drinking alcohol as it can cause excessive drowsiness with this medicine. It usually does not impair your ability to drive, but you should not drive if it makes you feel sleepy or dizzy. You must take adequate rest for a faster recovery, also take a healthy diet and drink plenty of water. Your doctor may ask for a few laboratory and diagnostic tests to know the effects of the medicine on your body.
Epixone-SL 250mg/125mg Injection is a combination of two medicines: Ceftriaxone and Sulbactam. Ceftriaxone is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Sulbactam is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Ceftriaxone against bacteria.
Can I experience an allergic reaction when using Epixone-SL 250mg/125mg Injection?
Yes, Epixone-SL 250mg/125mg Injection can cause an allergic reaction. If you have a known allergy to cephalosporin antibiotics or experience symptoms like hives, difficulty breathing, or swelling of the face, lips, tongue, or throat, seek immediate medical attention.
Can Epixone-SL 250mg/125mg Injection lead to gastrointestinal issues such as diarrhea?
Yes, using Epixone-SL 250mg/125mg Injection can cause diarrhea. As an antibiotic, it kills harmful bacteria but also affects beneficial bacteria in the stomach or intestine, leading to diarrhea. If you experience severe diarrhea, consult your doctor for guidance.
How long does it take for Epixone-SL 250mg/125mg Injection to start working?
Epixone-SL 250mg/125mg Injection typically begins working soon after administration. However, it may require several days to eradicate all harmful bacteria and bring about a noticeable improvement in symptoms.
What if I don't see improvements or experience worsening symptoms while using Epixone-SL 250mg/125mg Injection?
If you fail to notice improvements or experience worsening symptoms after completing the full course of treatment, inform your doctor. They will assess the situation and provide further guidance.
Can I stop taking Epixone-SL 250mg/125mg Injection once I feel better?
No, it is essential to complete the full course of treatment with Epixone-SL 250mg/125mg Injection even if you experience symptom improvement. Stopping prematurely may leave the infection untreated and potentially lead to complications.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Alcohol
Consuming alcohol with Epixone-SL 250mg/125mg Injection does not cause any harmful side effects.
Breastfeed
Epixone-SL 250mg/125mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Pregnancy
Epixone-SL 250mg/125mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.